Compare
Herbalife Ltd. vs Nu Skin Enterprises, Inc. vs Cardinal Health Inc vs Cencora, Inc.
| Latest fiscal year | Herbalife Ltd. HLF | Nu Skin Enterprises, Inc. NUS | Cardinal Health Inc CAH | Cencora, Inc. COR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-09-30 |
| Revenue | $5.04B | $1.49B | $254.25B | $321.33B |
| Revenue growth (YoY) | +0.9% | -14.3% | +14.2% | +9.3% |
| Gross margin | 77.9% | 69.4% | 3.8% | 3.6% |
| Operating margin | 9.5% | 4.4% | 1.0% | 0.8% |
| Net margin | 4.5% | 10.8% | 0.7% | 0.5% |
| Net income | $228.30M | $160.20M | $1.71B | $1.55B |
| EPS (Diluted) | $2.20 | $3.18 | $7.23 | $7.96 |
| Operating cash flow | $333.30M | $80.29M | $5.17B | $3.88B |
| Free cash flow | $252.90M | $46.01M | $4.53B | $3.21B |
| Cash & equivalents | $353.10M | $238.63M | $4.86B | $4.36B |
| Total assets | $2.79B | $1.41B | $57.30B | $76.59B |
| Total liabilities | $3.30B | $600.07M | n/a | n/a |
| Shareholders' equity | -$515.10M | $805.24M | -$2.88B | $1.51B |
| Return on year-end equity | n/a | 19.9% | n/a | 103.1% |
| Shares outstanding | 103.30M | n/a | n/a | 193.94M |
Revenue, most recent five fiscal years
| Fiscal year | Herbalife Ltd. | Nu Skin Enterprises, Inc. | Cardinal Health Inc | Cencora, Inc. |
|---|---|---|---|---|
| Latest | $5.04B Ended 2025-12-31 | $1.49B Ended 2025-12-31 | $254.25B Ended 2026-06-30 | $321.33B Ended 2025-09-30 |
| 1 year earlier | $4.99B Ended 2024-12-31 | $1.73B Ended 2024-12-31 | $222.58B Ended 2025-06-30 | $293.96B Ended 2024-09-30 |
| 2 years earlier | $5.06B Ended 2023-12-31 | $1.97B Ended 2023-12-31 | $226.83B Ended 2024-06-30 | $262.17B Ended 2023-09-30 |
| 3 years earlier | $5.20B Ended 2022-12-31 | $2.23B Ended 2022-12-31 | $204.98B Ended 2023-06-30 | $238.59B Ended 2022-09-30 |
| 4 years earlier | $5.80B Ended 2021-12-31 | $2.70B Ended 2021-12-31 | $181.33B Ended 2022-06-30 | $213.99B Ended 2021-09-30 |